About
Bioline Rx Ltd (TA:BLRX) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 26 2026
BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
Mar 23 2026
BioLineRx Reports 2025 Financial Results and Provides Corporate Update
Mar 16 2026
BioLineRx to Report 2025 Annual Results on March 23, 2026
Nov 24 2025
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 18 2025
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
Google Übersetzer